Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.15 - $0.63 $2,004 - $8,417
-13,361 Reduced 5.33%
237,491 $38,000
Q3 2022

Nov 14, 2022

BUY
$0.52 - $3.08 $3,574 - $21,171
6,874 Added 2.82%
250,852 $163,000
Q2 2022

Aug 12, 2022

BUY
$1.9 - $4.18 $12,876 - $28,327
6,777 Added 2.86%
243,978 $592,000
Q1 2022

May 13, 2022

BUY
$3.54 - $8.3 $74,478 - $174,623
21,039 Added 9.73%
237,201 $958,000
Q3 2021

Nov 12, 2021

BUY
$12.22 - $21.28 $187,222 - $326,030
15,321 Added 7.63%
216,162 $4.17 Million
Q2 2021

Aug 13, 2021

BUY
$9.0 - $15.94 $345,105 - $611,219
38,345 Added 23.6%
200,841 $2.77 Million
Q1 2021

May 12, 2021

BUY
$5.24 - $10.14 $851,479 - $1.65 Million
162,496 New
162,496 $1.47 Million

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.